# Leumi Partners

> Leumi Partners is a VC fund backing Software and Information Technology. See 12 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tel Aviv, Israel
- Total investments: 12
- Last investment: May 2026
- Lead investor: 50%
- Last updated: Aug 2026
- Website: http://www.leumipartners.com/en/

Leumi Partners is a VC fund in Tel Aviv focused on Software and Information Technology. Leumi Partners' services are delivered via our unique merchant banking platform and include investments by the Leumi Group, underwriting, financial analysis and research, strategic advice, Mergers and Acquisitions, as well as raising equity and debt.Conducting investment or providing services, their goal is to maintain a close-knitpartners promoting our partners' interests by presenting the most suitable solutions at any given time, whilst maintaining a long-term outlook.Leumi Partners has led some of the most complex and challenging transactions in the recent years within the Israeli market in the recent year and manages the Leumi Group's of over NIS 7 billion investment portfolio.

## Contacts

5 contacts available for Leumi Partners. Shizune tracks 4 team members at Leumi Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/leumi-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 6 | 50% |
| Information Technology | 3 | 25% |
| Analytics | 2 | 17% |
| Health Care | 2 | 17% |
| Financial Services | 2 | 17% |

37 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 4 | 33% |
| Private Equity | 2 | 17% |
| Series A | 1 | 8% |
| Series B | 1 | 8% |
| Series D | 1 | 8% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 6 | 50% |
| United States | 4 | 33% |
| United Kingdom | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Avraham Ortal | Co-founder & CEO | 0 | https://shizune.co/investors/profile/avraham-ortal |
| Lilach Katz | VP Finance | 0 | https://shizune.co/investors/profile/lilach-katz |
| Michal Rabinovitch | Deputy CEO, General Counsel | 0 | https://shizune.co/investors/profile/michal-rabinovitch |
| Yaron Bloch | CEO | 0 | https://shizune.co/investors/profile/yaron-bloch |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Landora Group | Landora Group develops, manufactures, and supplies a diverse range of high-quality ingredients and raw materials to Israel's food industry. | $67.9M | Private Equity | May 03, 2026 |  |
| Profit Financial Group | Profit Financial Group is an financial services firm offering financial planning, pension, insurance and investment solutions. | $31.9M | Secondary Market | Mar 30, 2026 |  |
| Tabit | Developer of a hospitality management platform designed to transform restaurants into fully mobile, cloud-based operations. The company's platform uses a truly mobile point-of-sale system that enables command and control of all aspects of restaurant operations including contactless pay and ordering, delivery, curbside pick-up, guestmanagement, kitchen display, business intelligence, shift management, and more - making restaurants more efficient and profitable while increasing customer satisfaction. Integrations with top hotel PMS providers like OPERA by Oracle, Roommaster, and Stayntouch bring operational efficiencies to hotels. | $40M | Series C | Aug 20, 2022 |  |
| OncoHost | OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy. The company utilizing proprietary proteomic analysis, we aim to understand the patient's unique response to therapy and overcome one of the major obstacles in clinical oncology today's resistance to therapy.Based on robust scientific infrastructure and a strong IP position, OncoHost is launching an extensive clinical program with leading academic and clinical partners.OncoHost's platform analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to given cancer therapy. Response Profiling also identifies potential drug targets, advancing the development of novel therapeutic strategies.OncoHost's profiling platform offers a new layer of information, enabling early identification of non-responsiveness to cancer treatments and the discovery of new targets to overcome treatment resistance.OncoHost was founded in 2017 and is headquartered in Binyamina, Israel. | $35M | Series C | May 10, 2022 |  |
| GigaSpaces Technologies | GigaSpaces provides the leading in-memory computing platform for fast data analytics and extreme transaction processing. With GigaSpaces InsightEdge Platform, and its core engine XAP, organizations can overcome the complex obstacles of big data and advanced analytics to deliver real-time business impact. Hundreds of Tier-1 and Fortune-listedorganizations worldwide leverage GigaSpaces across financial services, retail, transportation, telecom, healthcare, and others.GigaSpaces offices are located in the US, Europe and Asia. | $13.5M | Venture - Series Unknown | Nov 10, 2021 |  |
| GigaSpaces Technologies | GigaSpaces provides the leading in-memory computing platform for fast data analytics and extreme transaction processing. With GigaSpaces InsightEdge Platform, and its core engine XAP, organizations can overcome the complex obstacles of big data and advanced analytics to deliver real-time business impact. Hundreds of Tier-1 and Fortune-listedorganizations worldwide leverage GigaSpaces across financial services, retail, transportation, telecom, healthcare, and others.GigaSpaces offices are located in the US, Europe and Asia. | $13.5M | Venture - Series Unknown | Nov 10, 2021 |  |
| SafeBreach | SafeBreach is a pioneer in the emerging category of breach and attack simulation. The company's groundbreaking platform provides a “hacker's view” of an enterprise’s security posture to proactively predict attacks, validate security controls and improve SOC analyst response. SafeBreach automatically executes breach methods with anextensive and growing Hacker’s Playbook of research and real-world investigative data. SafeBreach is funded by Sequoia Capital, Deutsche Telekom Capital, Hewlett Packard Pathfinder and investor Shlomo Kramer. | $53.5M | Series D | Nov 09, 2021 |  |
| Locusview | Locusview equips energy, telecom, and water companies with a Digital Construction Management (DCM) platform to help them manage infrastructure capital projects from planning to revenue. The solution enables all stakeholders and contractors to streamline data flow and thereby manage the three crucial phases of infrastructure construction projects:Planning, Construction, and Close-Out. The result is a high fidelity Digital Twin, better operational awareness, and CapEx optimization. | $64M | Series A | Apr 28, 2021 |  |
| Seebo | Seebo helps customers unlock the full potential of their production lines. Seebo Process-Based Artificial Intelligence empowers manufacturing teams to achieve global process optimization across multiple, conflicting objectives – from improving quality, throughput, and yield, to reducing waste and scrap, cutting energy costs, and lowering emissions. | $15M | Series B | Mar 04, 2021 |  |
| Medisafe | Medisafe is a digital patient engagement platform, empowering patients to stay on top of all their medications. Its approach leverages the billions of data points collected to personalize patient engagement and improve adherence and persistence to medications.By addressing the major challenges of medication management utilizing a datascience-driven approach, Medisafe improves patient adherence and quality of care. The company provides its pharma and payer partners the opportunity to engage each patient on an individual level, supporting them throughout the entire patient journey, and provides unique insights on behavior patterns critical for improving the patient experience. Medisafe had shown over numerous studies, both retrospective with tens of thousands of patients as well as RCTs, that its solutions improve adherence by up to 20%.Founded following an accidental insulin overdose of the founder's father, the Medisafe solution currently has nearly 5 million registered users across iOS and Android smartphones, tablets, wearables, and Web solutions, who have recorded over 2 billion medication doses. Nearly 200,000 users have rated the app an average of 4.7 out of 5 stars in the App Store and Google Play store, making it the Top Rated solution in the category. Their accolades include Gartner Cool Vendors, Traction winner (Health 2.0 startup competition), Fast Company Most Innovative in Healthcare, Google and Apple Editors' Choice and Top Developer, etc. | $30M | Series C | Feb 25, 2021 |  |

10 of 12 investments shown.

## Co-investors
- [Fortissimo Capital](https://shizune.co/investors/profile/fortissimo-capital) — VC Fund, 4 deals together
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund, 3 deals together
- [ALIVE Israel HealthTech Fund](https://shizune.co/investors/profile/alive-israel-healthtech-fund) — VC Fund, 2 deals together
- [BRM Capital](https://shizune.co/investors/profile/brm-capital) — VC Fund, 2 deals together
- [Claridge Israel](https://shizune.co/investors/profile/claridge-israel) — VC Fund, 2 deals together
- [Israel Growth Partners](https://shizune.co/investors/profile/israel-growth-partners) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Leumi Partners invest in?

Leumi Partners invests primarily in Software, Information Technology and Analytics startups, most often at Series C and Private Equity stage. Most of the 12 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Leumi Partners?

Public channels for Leumi Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Leumi Partners?

The team at Leumi Partners includes Avraham Ortal (Co-founder & CEO), Lilach Katz (VP Finance) and Michal Rabinovitch (Deputy CEO, General Counsel). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co